ClinicalTrials.gg
Not yet recruitingNCT07837947Updated Sep 24, 2026

Air Polishing for Pain and Compliance in Supportive Periodontal Therapy

An interventional study of Trehalose Air-Polishing and Ultrasonic Instrumentation in Periodontitis, sponsored by Octavi Camps-Font. Not yet recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-24.

Sponsored by Octavi Camps-Font · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Supportive periodontal therapy (SPT) is essential for maintaining periodontal stability and preventing disease recurrence in patients who have been successfully treated for periodontitis. However, long-term effectiveness depends on regular attendance at maintenance visits, and negative experiences associated with periodontal instrumentation, such as pain or discomfort, may affect patient acceptance and adherence to the maintenance program.

The aim of this randomized clinical trial is to evaluate whether supportive periodontal therapy performed using an air-polishing device with low-abrasive trehalose powder reduces patient-perceived pain and improves the clinical experience compared with conventional biofilm removal using ultrasonic instrumentation. The study will also assess whether the use of air polishing is associated with better adherence to the periodontal maintenance program while maintaining comparable periodontal clinical outcomes.

Forty periodontally stabilized adult patients enrolled in the supportive periodontal therapy program of the Master's Degree in Periodontology and Peri-implantology at the University of Barcelona will be randomly allocated in a 1:1 ratio to one of two parallel treatment groups. The control group will receive conventional supportive periodontal therapy using ultrasonic instrumentation, while the experimental group will receive supportive periodontal therapy using an air-polishing device with low-abrasive trehalose powder. Participants will be followed for 24 months.

The primary outcome will be patient-perceived pain associated with supportive periodontal therapy, assessed using a visual analogue scale (VAS). Secondary outcomes will include treatment duration, adherence to scheduled maintenance visits, patient experience and acceptance of treatment, and periodontal clinical parameters. Periodontal status will be monitored throughout follow-up by assessing probing pocket depth, clinical attachment level, bleeding on probing, and plaque index.

This study aims to determine whether air polishing with trehalose powder can provide a more comfortable and patient-centered approach to supportive periodontal therapy without compromising periodontal clinical outcomes, and whether an improved treatment experience may contribute to better long-term adherence to periodontal maintenance.

Read the detailed description

Periodontitis is a chronic inflammatory disease that requires long-term supportive periodontal therapy (SPT) after completion of active periodontal treatment in order to maintain periodontal stability and reduce the risk of disease recurrence. The effectiveness of SPT is strongly influenced by long-term patient adherence. Therefore, improving patient comfort and treatment experience during maintenance visits may contribute to better adherence to periodontal maintenance programs.

Conventional SPT commonly involves mechanical removal of supra- and subgingival biofilm and deposits using ultrasonic instrumentation. Air-polishing devices using low-abrasive powders have been proposed as an alternative approach for biofilm removal during periodontal maintenance. Previous studies suggest that air polishing may provide effective biofilm removal while reducing patient discomfort and treatment time. However, evidence regarding the use of newer-generation air-polishing systems with trehalose-based powder during SPT remains limited. This study will therefore evaluate both patient-reported outcomes and periodontal clinical outcomes associated with this approach.

This study is designed as a randomized, superiority, parallel-group clinical trial with a 24-month follow-up period. A total of 40 periodontally stabilized adult patients enrolled in the SPT program of the Master's Degree in Periodontology and Peri-implantology at the University of Barcelona will be included. Participants who meet the eligibility criteria and provide written informed consent will be randomly allocated in a 1:1 ratio to either the experimental group or the control group, with an expected sample of 20 participants per group.

Participants allocated to the control group will receive conventional biofilm removal using ultrasonic instrumentation during supportive periodontal therapy. Participants allocated to the experimental group will receive supportive periodontal therapy using an air-polishing device with low-abrasive trehalose powder. The purpose of this comparison is to determine whether the air-polishing approach reduces patient-perceived pain and improves the overall treatment experience and adherence to the maintenance program compared with conventional ultrasonic instrumentation, while maintaining comparable periodontal clinical outcomes.

Participants will be prospectively evaluated at baseline and during follow-up visits over a period of 24 months. Maintenance visits will be performed every 6 months. At each maintenance visit, a complete periodontal examination will be performed. Periodontal clinical parameters will include probing pocket depth, clinical attachment level, bleeding on probing, and plaque index.

The primary outcome of the study will be patient-perceived pain associated with supportive periodontal therapy. Immediately after treatment, perceived pain will be assessed using a visual analogue scale (VAS). Secondary outcomes will include patient experience, adherence to the periodontal maintenance program, treatment duration, and periodontal clinical outcomes. Adherence will be evaluated according to attendance at scheduled maintenance visits throughout the follow-up period.

Data will be prospectively collected using a specific electronic data collection form, including demographic and clinical variables as well as patient-experience questionnaires. Investigators responsible for clinical examinations will undergo calibration before participant recruitment.

Statistical analyses will be conducted according to the intention-to-treat principle, with patient-perceived pain considered the primary outcome variable. The study is designed to determine whether the use of air polishing with trehalose powder provides a superior patient experience, particularly in terms of perceived pain, compared with conventional ultrasonic instrumentation, while also assessing whether both approaches provide comparable periodontal clinical outcomes over time.

The study will be conducted at the University of Barcelona Dental Hospital (Hospital Odontològic Universitat de Barcelona), in the clinical facilities of the Master's Degree in Periodontology and Peri-implantology. Recruitment, diagnosis, and treatment of participants will be performed by residents of the Master's program under the supervision of the study investigators.

By simultaneously evaluating patient-reported outcomes, adherence, treatment efficiency, and periodontal clinical parameters, this study seeks to determine whether air polishing with trehalose powder may represent a more comfortable and patient-centered approach to supportive periodontal therapy without compromising periodontal stability. If improved comfort is associated with better adherence to scheduled maintenance visits, this approach could contribute to optimizing long-term periodontal maintenance protocols.

02

Conditions studied

  • Periodontitis

Keywords

  • Supportive Periodontal Therapy
  • Periodontal Maintenance
  • Air Polishing
  • Trehalose
  • Ultrasonic Instrumentation
  • Pain
  • Patient-Reported Outcomes
03

In context

Periodontitis

1,231 studies on the registry are indexed under Periodontitis; 295 are open to participants now.

This study's planned enrollment of 40 is close to the median of 44 across 846 interventional studies indexed under Periodontitis.

Browse Periodontitis studies →

Lead sponsor

Octavi Camps-Font is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Men or women aged 18 years or older who voluntarily agree to sign the form before any study-related procedure is performed.
  • I or II.
  • Initial diagnosis of Stage I-III periodontitis according to the 2017 World Workshop, periodontally treated and stabilized, and enrolled in a supportive periodontal therapy (SPT) program.
  • Non-smokers or light smokers (\<10 cigarettes/day).
  • Commitment to attend all follow-up visits over the 24-month study period.

Exclusion criteria

Exclusion Criteria:

  • Patients requiring local anesthesia or anxiolytic premedication to undergo supportive periodontal therapy (SPT).
  • Patients with pacemakers, implantable cardioverter-defibrillators, or neurostimulators.
  • Pregnant women.
  • Patients with infectious respiratory diseases.
  • Patients with systemic diseases or neurological disorders that may alter pain perception.
  • Patients receiving medications that may influence pain perception (e.g., opioids or gabapentin).
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Trehalose Air-Polishing Group

    Participants allocated to this group will receive supportive periodontal therapy (SPT) using an air-polishing device with low-abrasive trehalose powder for subgingival biofilm removal.

    Device: Trehalose Air-Polishing

  • Active comparator
    Ultrasonic Instrumentation Group

    Participants allocated to this group will receive supportive periodontal therapy (SPT) using conventional ultrasonic instrumentation for subgingival biofilm and calculus removal.

    Device: Ultrasonic Instrumentation

Interventions

  • DeviceTrehalose Air-Polishing

    Subgingival biofilm removal during supportive periodontal therapy using an air-polishing device with low-abrasive trehalose powder.

  • DeviceUltrasonic Instrumentation

    Conventional subgingival debridement during supportive periodontal therapy using ultrasonic instrumentation.

06

What researchers measure

Primary outcomes

  1. Pain perceived during supportive periodontal therapy

    Pain perceived by the participant during the supportive periodontal therapy session will be assessed using a Visual Analogue Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). The outcome will be compared between participants treated with trehalose air-polishing and those treated with ultrasonic instrumentation.

    Time frame: Immediately after the supportive periodontal therapy session

Secondary outcomes

  1. Patient-reported treatment experience

    Patient-reported experience with supportive periodontal therapy will be assessed using a structured questionnaire after treatment. The questionnaire will evaluate aspects related to comfort, treatment perception, satisfaction, and preference, allowing comparison between trehalose air-polishing and ultrasonic instrumentation.

    Time frame: Immediately after each supportive periodontal therapy session

  2. Duration of supportive periodontal therapy session

    Duration of the supportive periodontal therapy session, measured in minutes from the effective start of the clinical procedure until completion of the periodontal treatment scheduled for that visit.

    Time frame: At each supportive periodontal therapy visit throughout the 24-month follow-up

  3. Adherence to supportive periodontal therapy

    Adherence to the supportive periodontal therapy program will be assessed based on attendance at scheduled maintenance visits. Adherence will be determined from the proportion of scheduled visits attended by each participant during the follow-up period.

    Time frame: Throughout the 24-month follow-up

  4. Probing pocket depth (PPD)

    Probing pocket depth will be measured at six sites per tooth using a UNC-15 periodontal probe and expressed in millimeters.

    Time frame: Baseline and at each supportive periodontal therapy visit throughout the 24-month follow-up

  5. Clinical attachment level (CAL)

    Clinical attachment level will be measured at six sites per tooth using a UNC-15 periodontal probe and expressed in millimeters.

    Time frame: Baseline and at each supportive periodontal therapy visit throughout the 24-month follow-up.

  6. Gingival margin position (MG)

    Gingival margin position will be measured at six sites per tooth using a UNC-15 periodontal probe and expressed in millimeters.

    Time frame: Baseline and at each supportive periodontal therapy visit throughout the 24-month follow-up.

  7. Bleeding on probin (BoP)

    Bleeding on probing will be recorded at six sites per tooth and expressed as the percentage of sites presenting bleeding after periodontal probing.

    Time frame: Baseline and at each supportive periodontal therapy visit throughout the 24-month follow-up.

  8. Plaque index (PI)

    Plaque will be recorded at six sites per tooth and expressed as the percentage of sites presenting plaque.

    Time frame: Baseline and at each supportive periodontal therapy visit throughout the 24-month follow-up.

  9. Patient knowledge and awareness of supportive periodontal therapy

    Patient knowledge and awareness regarding periodontitis and the importance of supportive periodontal therapy will be assessed using an 8-item questionnaire. Each correct response will receive 1 point and each incorrect response 0 points, resulting in a total score ranging from 0 to 8. Higher scores indicate greater knowledge and awareness of periodontitis and supportive periodontal therapy.

    Time frame: Throughout the 24-month follow-up

  10. Patient-reported perceived knowledge of periodontal disease and supportive periodontal therapy

    Participants will rate their perceived level of knowledge regarding their periodontal disease and supportive periodontal therapy on a numerical rating scale ranging from 1 to 10, with higher scores indicating a greater self-perceived level of knowledge.

    Time frame: Throughout the 24-month follow-up.

07

Study locations

1 site
  • Hospital Odontològic Universitat de Barcelona
    L'Hospitalet de Llobregat, Barcelona 08907, Spain
    • Edgar Martínez García, DDS · Contactemartiga248@alumnes.ub.edu · +34 689484177
    • Octavi Camps Font, DDS, MSc, PhD · Contactocamps@ub.edu · +34 665980569
    • Enrique Manuel Roldán Carrera, DDS, MSc · Sub investigator
    • Albert González Barnadas, DDS, MSc, PhD · Sub investigator
    • Jaume Miranda Rius, DDS, MSc, PhD · Sub investigator
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared with external researchers, in accordance with the study protocol and applicable data protection regulations.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07837947
Lead sponsor
Octavi Camps-Font
Responsible party
Octavi Camps-Font (Associate Professor, University of Barcelona) — Sponsor-investigator
First posted
Sep 24, 2026
Start date
Oct 2026 (estimated)
Primary completion
Oct 2026 (estimated)
Completion
May 2027 (estimated)
Last update
Sep 24, 2026

Study contacts

Octavi Camps Font, DDS, MSc, PhD
Contact
ocamps@ub.edu
+34 665980569
Edgar Martínez García, DDS
principal investigator · University of Barcelona

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion